Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease
Clinical trial NCT07417696 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07417696
- Sponsor
- Chinese Medical Association
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2029-03-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.